longbridge
  • Explore
    Products
    Private Wealth ManagementUS StocksSG StocksHK StocksUS OptionsUS Pre-Market OptionsETFsREITsWarrantsCash Plus
    Tools
    Longbridge SkillLongbridge AILongbridge APIPaper TradingDividend HubLongbridge Pro
  • Café
longbridge

CAM INNODRUGS-R

83525

7.9102.41% ( -0.195 )
Delay Closed: Nov 16, 16:08:00
Start trading
OverviewOverviewNewsNewsPostsPostsWikiWikiRatingsRatingsCompositionCompositionDividendsDividends

Overview

CAM INNODRUGS-R (83525)

Open
7.910
High
7.910
Low
7.910
Prev. Close
8.105
Volume
0
Turnover
0
Avg Price
--
Bid/Ask Ratio
100.00%
Amplitude
0.00%
52wk High
8.700
Volume Ratio
0.00
Turnover Ratio
--
52wk Low
7.750
Dividend YieldTTM
--
DividendTTM
--
NAV
--
NAV Date
--
Disc/Prem Rate
--
Total Issued
0.00
Assets
--
Min lot size
100
Currency
CNY

News

  • Tip Ranks · Nov 16, 2026 at 10:40 AM

    CSPC Initiates China Trial of SYH2051 Combination Therapy

  • AASTOCKS News · Nov 16, 2026 at 08:47 AM

    HSI Gains 116 Pts for Day; NEW WORLD DEV Plunges 40%, MINIMAX-W Hits New Low with 18% Drop, AKESO Slumps 22%

  • AASTOCKS News · Nov 16, 2026 at 08:13 AM

    HSI Closes at 23,753, Up 116 pts; HSTI Closes at 3,801, Down 11 pts; AKESO Down over 22%; MENGNIU DAIRY, CKI HOLDINGS, BANK OF CHINA, MIDEA GROUP, COSCO SHIP PORT Hit New Highs; Market Turnover Rises

  • Yicai · Nov 16, 2026 at 07:53 AM

    China’s Akeso Sinks After US FDA Rejects License Application for Its Cancer Drug

  • AASTOCKS News · Nov 16, 2026 at 07:32 AM

    Citi Cuts AKESO TP to HKD163 as US FDA Rejects New Lung Cancer Drug

  • PUBT · Nov 16, 2026 at 06:17 AM

    Akeso's Gumokimab Wins China Approval for Active Ankylosing Spondylitis

LongbridgeAI
© 2026 Longbridge|Terms of ServicePrivacy Policy